DFDA

Intensive Insulin Therapy

Treatment for Chronic Kidney Disease Due To Diabetes Mellitus Type 1

Typical Dosage: Individualized, typically 0.4-1.0 units/kg/day

Effectiveness
90%
Safety Score
55%
Clinical Trials
500
Participants
500K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
Individualized, typically 0.4-1.0 units/kg/day
Time to Effect
Years for complication prevention, immediate for glucose control
Treatment Duration
Lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
10(Treat 10 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$4,000
Monitoring:$8,000
Side Effect Mgmt:$500
Total Annual:$12,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$15,000/QALY
QALYs Gained
1.8
Intensive Insulin Therapy Outcomes

for Chronic Kidney Disease Due To Diabetes Mellitus Type 1

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Common Side Effects
Hypoglycemia
+90%
Weight gain
+60%
Injection site reactions
+15%

Sources:

nih.gov
nih.gov
diabetesjournals.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov